Inactivation of tautomerase activity of macrophage migration inhibitory factor by sulforaphane: A potential biomarker for anti-inflammatory intervention

Cancer Epidemiology Biomarkers and Prevention

Volumn 20, Issue 7, 2011, Pages 1516-1523

  Healy, Zachary R ^a   Liu, Hua ^a   Holtzclaw, W David ^a   Talalay, Paul ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BENZYL ISOTHIOCYANATE; DOPACHROME; MACROPHAGE MIGRATION INHIBITION FACTOR; PHENETHYL ISOTHIOCYANATE; SULFORAPHANE;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; DRUG SENSITIVITY; ENZYME ACTIVITY; ENZYME INACTIVATION; HUMAN; MACROPHAGE MIGRATION; MICROTITER PLATE ASSAY; MOUSE; NONHUMAN; PRIORITY JOURNAL; SPECTROPHOTOMETRY; ULTRAFILTRATION;

ANIMALS; BIOLOGICAL MARKERS; ENZYME INHIBITORS; HUMANS; INFLAMMATION; INTRAMOLECULAR OXIDOREDUCTASES; ISOTHIOCYANATES; MACROPHAGE MIGRATION-INHIBITORY FACTORS; MICE; SENSITIVITY AND SPECIFICITY; SPECTROPHOTOMETRY; THIOCYANATES;

EID: 79960095905     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-11-0279     Document Type: Article

References (38)

1. Baugh JA, Bucala R. Macrophage migration inhibitory factor. Crit Care Med 2002;30 (Suppl. 1):S27-35.
2. Bucala R, editor. MIF, Most Interesting Factor. Singapore: World Scientific Publishing Co.; 2007.
3. Cooke G, Armstrong ME, Donnelly SC. Macrophage migration inhibitory factor (MIF), enzymatic activity and the inflammatory response. Biofactors 2009;35:165-8.
4. Grieb G, Merk M, Bernhagen J, Bucala R. Macrophage migration inhibitory factor (MIF): A promising biomarker. Drug News and Perspect 2010;23:257-64.
5. Sun H, Swope M, Cinquina C, Bedarkar S, Bernhagen J, Bucala R, et al. The subunit structure of human macrophage migration inhibitory factor: evidence for a trimer. Protein Eng 1996;9:631-5. (Pubitemid 26275709)
6. Lubetsky JB, Swope M, Dealwis C, Blake P, Lolis E. Pro-1 of macrophage migration inhibitory factor functions as a catalytic base in the phenylpyruvate tautomerase activity. Biochemistry 1999;38:7346-54.
7. Stivers JT, Abeygunawardana C, Mildvan AS, Hajipour G, Whitman CP, Chen LH. Catalytic role of the amino-terminal proline in 4-oxalocrotonate tautomerase: Affinity labeling and heteronuclear NMR studies. Biochemistry 1996a;35:803-13. (Pubitemid 26034564)
8. a values of active site residues. Biochemistry 1996b;35:814-23.
9. Rosengren E, Bucala R, Aman P, Jacobsson L, Odh G, Metz CN, et al. The immunoregulatory mediator macrophage migration inhibitory factor (MIF) catalyzes a tautomerization reaction. Mol Med 1996;2:143-9.
10. Rosengren E, Aman P, Thelin S, Hansson C, Ahlfors S, Bjo{combining double acute accent}rk P, et al. The macrophage migration inhibitory factor MIF is a phenylpyruvate tautomerase. FEBS Lett 1997;417:85-8.
11. Whitman CP. The 4-oxalocrotonate tautomerase family of enzymes: how nature makes new enzymes using a β-α-β structure motif. Arch Biochem Biophys 2002;402:1-13. (Pubitemid 34848289)
12. Poelarends GJ, Veetil VP, Whitman CP. The chemical versatility of the β-α-β fold: catalytic promiscuity and divergent evolution in the tautomerase superfamily. Cell Mol Life Sci 2008;65:3606-18.
13. Stamps SL, Fitzgerald MC, Whitman CP. Characterization of the role of the amino-terminal proline in the enzymatic activity catalyzed by macrophage migration inhibitory factor. Biochemistry 1998;37:10195-202. (Pubitemid 28366375)
14. Brown KK, Blaiki FH, Smith RAJ, Tydball JDA, Lue H, Bernhagen J, et al. Direct modification of the proinflammatory cytokine macrophage migration inhibitory factor by dietary isothiocyanates. J Biol Chem 2009;284:32425-33.
15. Cross JV, Rady JM, Foss FW, Lyons CE, Macdonald TL, Templeton DJ. Nutrient isothiocyanates covalently modify and inhibit the inflammatory cytokine macrophage migration inhibitory factor (MIF). Biochem J 2009;423:315-21.
16. Ouertatani-Sakouhi H, El-Turk F, Fauvet B, Roger T, Le Roy D, Karpinar DP, et al. A new class of isothiocyanate-based irreversible inhibitors of macrophage migration inhibitory factor. Biochemistry 2009;48:9858-70.
17. Zhang Y, Talalay P, Cho C-G, Posner GH. A major inducer of anti-carcinogenic protective enzymes from broccoli: isolation and elucidation of structure. Proc Natl Acad Sci U S A 1992;89:2399-403.
18. Talalay P, Dinkova-Kostova AT, Holtzclaw WD. Importance of phase 2 gene regulation in protection against electrophile and reactive oxygen toxicity and carcinogenesis. Adv Enzyme Regul 2003;43:121-34. (Pubitemid 36872827)
19. Motohashi H, Yamamoto M. Nrf2-Keap1 defines a physiologically important stress response mechanism. Trends Mol Med 2004;10:549-57. (Pubitemid 39433824)
20. Kensler TW, Wakabayashi N, Biswal S. Cell survival responses to environmental stresses via the Keap1-Nrf2-ARE pathway. Ann Rev Pharmacol Toxicol 2007;47:89-116.
21. Bozza M, Satoskar AR, Lin G, Lu B, Humbles AA, Gerard C, et al. Targeted disruption of migration inhibitory factor gene reveals its critical role in sepsis. J Exp Med 1999;189:341-6. (Pubitemid 29063255)
22. Calandra T, Echtenacher B, Roy DL, Pugin J, Metz CN, H€ultner L, et al. Protection from septic shock by neutralization of macrophage migration inhibitory factor. Nat Med 2000;6:164-70. (Pubitemid 30082360)
23. Gadjeva M, Nagashima J, Zaidi T, Mitchell RA, Pier GB. Inhibition of macrophage migration inhibitory factor ameliorates ocular Pseudomonas aeruginosa-induced keratitis. PloS Pathog 2010;6:e1000826.
24. Senter PD, Al-Abed T, Metz CN, Benigni F, Mitchell RA, Chesney J, et al. Inhibition of macrophage migration inhibitory factor (MIF) tautomerase and biological activities by acetaminophen metabolites. Proc Natl Acad Sci U S A 2002;99:144-9. (Pubitemid 34060331)
25. Suganuma H, Fahey JW, Bryan KE, Healy ZR, Talalay P. Stimulation of phagocytosis by sulforaphane. Biochem Biophys Res Commun 2011;405:146-51.
26. Al-Abed Y, Dabideen D, Aljabari B, Valster A, Messmer D, Ochani M, et al. ISO-1 binding to the tautomerase active site of MIF inhibits its pro-inflammatory activity and increases survival in severe sepsis. J Biol Chem 2005;280:36541-4. (Pubitemid 41587728)
27. Dabideen DR, Cheng KF, Aljabari B, Miller EJ, Pavlov VA, Al-Abed Y. Phenolic hydrazones are potent inhibitors of macrophage migration inhibitory factor proinflammatory activity and survival improving agents in sepsis. J Med Chem 2007;50:1993-7. (Pubitemid 46626609)
28. Winner M, Meier J, Zierow S, Rendon BE, Crichlow GV, Riggs R, et al. A novel, macrophage migration inhibitory factor suicide substrate inhibits motility and growth of lung cancer cells. Cancer Res 2008;68:7253-7.
29. Fingerle-Rowson G, Kaleswarapu DR, Schlander C, Kabgani N, Brocks T, Reinart N, et al. A tautomerase-null macrophage migration-inhibitory factor (MIF) gene knock-in mouse model reveals that protein interactions and not enzymatic activity mediate MIF-dependent growth regulation. Mol Cell Biol 2009;29:1922-32.
30. Kithcart AP, Cox GM, Sielecki T, Short A, Pruitt J, Papenfuss T, et al. A small-molecule inhibitor of macrophage migration inhibitory factor for the treatment of inflammatory disease. FASEB J 2010;24:4459-66.
31. Fahey JW, Zhang Y, Talalay P. Broccoli sprouts: an exceptionally rich source of inducers of enzymes that protect against chemical carcinogens. Proc Natl Acad Sci U S A 1997;94:10367-72. (Pubitemid 27407048)
32. Bernhagen J, Mitchell RA, Calandra T, Voelter W, Cerami A, Bucala R. Purification, bioactivity and secondary structure analysis of mouse and human macrophage migration inhibitory factor (MIF). Biochemistry 1994;33:14144-55. (Pubitemid 24382359)
33. Smith PK, Krohn RI, Hermanson GT, Mallia AK, Gartner FH, Provenzano MD, et al. Measurement of protein using bicinchoninic acid. Anal Biochem 1985;150:76-85. (Pubitemid 16258399)
34. Bendrat K, Al-Abed Y, Callaway DJE, Peng T, Calandra T, Metz CN, et al. Biochemical and mutational investigations of the enzymatic activity of macrophage migration inhibitory factor. Biochemistry 1997;36:15356-62. (Pubitemid 27528002)
35. Chou TC, Talalay P. Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors. Adv Enzyme Regul 1984;22:27-55.
36. Aroca P, Solano F, Garcia-Borron JC, Lozano JA. Specificity of dopachrome tautomerase and inhibition by carboxylated indoles. Biochem J 1991;277:393-7.
37. Jarabak JA, Seeds AE Jr, Talalay P. Reversible cold-inactivation of 17β-hydroxysteroid dehydrogenase of human placenta: protective effect of glycerol. Biochemistry 1966;5:1269-79.
38. Shapiro TA, Fahey JW, Wade KL, Stephenson KK, Talalay P. Chemoprotective glucosinolates and isothiocyanates of broccoli sprouts: metabolism and excretion in humans. Cancer Epidemiol Biomarkers Prev 2001;10:501-8. (Pubitemid 32701637)